COVID-19 Vaccine Timeline Expectations Have Become Unrealistic, Warns Porges
Herd Immunity Goal Could Be Years Away
Despite record-breaking speed bringing several vaccine candidates into Phase I trials, the road ahead is likely to be much more treacherous and slow, warns one analyst.
You may also be interested in...
After partnering with Merck KGaA and Cobra Biologics, Oxford University has now tied up with Serum Institute of India to manufacture its COVID-19 vaccine and a marketing pact is likely. With clinical trials of the ChAdOx1 nCoV-19 vaccine underway, Serum intends to set aside other COVID-19 vaccine development plans for the time being.
Many clinicians doubt that aducanumab can really help slow the decline in Alzheimer’s patients – but US FDA could offer it the benefit of the doubt.
Timing means full EU approval could coincide with US FDA authorization later this year.